ReviewFrontiers in oncology2022

MDM2 inhibitors-mediated disruption of mitochondrial metabolism: A novel therapeutic strategy for retinoblastoma.

Arianna Romani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.